BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28159016)

  • 41. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
    Reich N; Maurer B; Akhmetshina A; Venalis P; Dees C; Zerr P; Palumbo K; Zwerina J; Nevskaya T; Gay S; Distler O; Schett G; Distler JH
    Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?
    Manetti M; Rosa I; Milia AF; Guiducci S; Carmeliet P; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2014 Sep; 73(9):1700-9. PubMed ID: 23852693
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis.
    Stenström M; Nyhlén HC; Törngren M; Liberg D; Sparre B; Tuvesson H; Eriksson H; Leanderson T
    J Dermatol Sci; 2016 Jul; 83(1):52-9. PubMed ID: 27156795
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis.
    Hasegawa M; Matsushita Y; Horikawa M; Higashi K; Tomigahara Y; Kaneko H; Shirasaki F; Fujimoto M; Takehara K; Sato S
    Arthritis Rheum; 2009 Nov; 60(11):3465-75. PubMed ID: 19877032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone Marrow-Derived Mesenchymal Stem Cells Expressing Thioredoxin 1 Attenuate Bleomycin-Induced Skin Fibrosis and Oxidative Stress in Scleroderma.
    Jiang M; Yu Y; Luo J; Gao Q; Zhang L; Wang Q; Zhao J
    J Invest Dermatol; 2017 Jun; 137(6):1223-1233. PubMed ID: 28132855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Wenyang Huazhuo Tongluo formula alleviates pulmonary vascular injury and downregulates HIF-1α in bleomycin-induced systemic sclerosis mouse model.
    Li K; Wang Q; Lv Q; Guo K; Han L; Duan P; Deng Y; Bian H
    BMC Complement Med Ther; 2022 Jun; 22(1):167. PubMed ID: 35733188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis.
    Takahashi T; Asano Y; Noda S; Aozasa N; Akamata K; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Tada Y; Sugaya M; Kadono T; Sato S
    Br J Dermatol; 2015 Sep; 173(3):681-9. PubMed ID: 25781362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
    Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
    Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.
    Distler JH; Jüngel A; Pileckyte M; Zwerina J; Michel BA; Gay RE; Kowal-Bielecka O; Matucci-Cerinic M; Schett G; Marti HH; Gay S; Distler O
    Arthritis Rheum; 2007 Dec; 56(12):4203-15. PubMed ID: 18050252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tie2 as a novel key factor of microangiopathy in systemic sclerosis.
    Moritz F; Schniering J; Distler JHW; Gay RE; Gay S; Distler O; Maurer B
    Arthritis Res Ther; 2017 May; 19(1):105. PubMed ID: 28545512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dihydroartemisinin alleviates skin fibrosis and endothelial dysfunction in bleomycin-induced skin fibrosis models.
    Li R; Yin H; Wang J; He D; Yan Q; Lu L
    Clin Rheumatol; 2021 Oct; 40(10):4269-4277. PubMed ID: 34013490
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pantethine Prevents Murine Systemic Sclerosis Through the Inhibition of Microparticle Shedding.
    Kavian N; Marut W; Servettaz A; Nicco C; Chéreau C; Lemaréchal H; Guilpain P; Chimini G; Galland F; Weill B; Naquet P; Batteux F
    Arthritis Rheumatol; 2015 Jul; 67(7):1881-90. PubMed ID: 25776044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin.
    Mackiewicz Z; Sukura A; Povilenaité D; Ceponis A; Virtanen I; Hukkanen M; Konttinen YT
    Clin Exp Rheumatol; 2002; 20(5):641-6. PubMed ID: 12412194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potential roles of interleukin-17A in the development of skin fibrosis in mice.
    Okamoto Y; Hasegawa M; Matsushita T; Hamaguchi Y; Huu DL; Iwakura Y; Fujimoto M; Takehara K
    Arthritis Rheum; 2012 Nov; 64(11):3726-35. PubMed ID: 22833167
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis.
    Huang J; Maier C; Zhang Y; Soare A; Dees C; Beyer C; Harre U; Chen CW; Distler O; Schett G; Wollin L; Distler JHW
    Ann Rheum Dis; 2017 Nov; 76(11):1941-1948. PubMed ID: 28814429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis.
    Takahashi T; Asano Y; Ichimura Y; Toyama T; Taniguchi T; Noda S; Akamata K; Tada Y; Sugaya M; Kadono T; Sato S
    Arthritis Rheumatol; 2015 Jan; 67(1):254-65. PubMed ID: 25302613
    [TBL] [Abstract][Full Text] [Related]  

  • 57. α2-antiplasmin modulates bone formation by negatively regulating osteoblast differentiation and function.
    Kanno Y; Ishisaki A; Kuretake H; Maruyama C; Matsuda A; Matsuo O
    Int J Mol Med; 2017 Sep; 40(3):854-858. PubMed ID: 28677806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single Cell RNA Sequencing Identifies HSPG2 and APLNR as Markers of Endothelial Cell Injury in Systemic Sclerosis Skin.
    Apostolidis SA; Stifano G; Tabib T; Rice LM; Morse CM; Kahaleh B; Lafyatis R
    Front Immunol; 2018; 9():2191. PubMed ID: 30327649
    [No Abstract]   [Full Text] [Related]  

  • 59. Angiogenesis and vasculogenesis in systemic sclerosis.
    Distler JH; Gay S; Distler O
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii26-7. PubMed ID: 16987827
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
    Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A
    Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.